Skip to search formSkip to main contentSkip to account menu

morpholinoanthracycline MX2

Known as: 3'-deamino-3'-morpholino-13-deoxy-10-hydroxycarminomycin, MX-2, morpholinoanthracycline MX-2 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
1993
1993
We performed a preliminary phase II clinical trial of MX2; 3'-deamino-3'-morpholino-13-deoxy-10-hydroxycarminomycin (KRN8602) in… 
Highly Cited
1989
Highly Cited
1989
A new model to predict antitumor activity of new analogues was developed, and the cross-resistance against cisplatin (CDDP) and… 
1988
1988
MX-2, a new morpholino anthracycline derivative, showed broad anti-neoplastic activity against experimental tumors. Molecular…